Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-24-047070
Filing Date
2024-11-15
Accepted
2024-11-15 16:05:21
Documents
1
Period of Report
2024-11-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 6999
  Complete submission text file 0001140361-24-047070.txt   8509
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Issuer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
MCLAUGHLIN KEVIN F (Reporting) CIK: 0001214938 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35280 | Film No.: 241467809